Literature DB >> 2341493

Effect of ciprofloxacin on the pharmacokinetics of antipyrine in healthy volunteers.

K K Tan1, M C Allwood, S Shawket.   

Abstract

The pharmacokinetics of antipyrine was studied in six healthy male volunteers before and during a 6-day course of 750 mg oral ciprofloxacin b.d. Antipyrine clearance was significantly decreased and the half-life significantly prolonged (P less than 0.05) during ciprofloxacin treatment. No significant difference in the apparent volume of distribution of antipyrine was observed. The results of this study suggest that ciprofloxacin is a potent inhibitor of hepatic drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341493     DOI: 10.1111/j.1365-2710.1990.tb00370.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  4 in total

1.  No influence of ciprofloxacin on ethanol disposition. A pharmacokinetic-pharmacodynamic interaction study.

Authors:  F Kamali
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 2.  Drug interactions with quinolone antibacterials.

Authors:  J R Brouwers
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

3.  The influence of steady-state ciprofloxacin on the pharmacokinetics and pharmacodynamics of a single dose of diazepam in healthy volunteers.

Authors:  F Kamali; S H Thomas; C Edwards
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients.

Authors:  Yuanyuan Wang; Muh Akbar Bahar; Anouk M E Jansen; Janwillem W H Kocks; Jan-Willem C Alffenaar; Eelko Hak; Bob Wilffert; Sander D Borgsteede
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.